ArticlePublished 28 Mar 2025
Impact of Recipient Polymorphisms in the KRAS Gene rs712 on the Overall Survival Rate of Hepatocellular Cancer Following Liver Transplantation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and a leading cause of cancer-related mortality worldwide. Liver transplantation (LT) is a curative treatment option for patients with HCC, particularly those who meet Milan criteria. However, the overall survival (OS) rates following LT for HCC vary significantly between individuals, suggesting that genetic factors may influence patient outcomes. This article explores the potential impact of recipient polymorphisms in the KRAS gene, specifically the rs712 polymorphism, on the survival rate of HCC patients following liver transplantation. The role of genetic variability in treatment response and prognosis following LT is of growing interest, and this article provides an overview of recent research examining the KRAS gene’s role in HCC and liver transplantation outcomes.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Practice
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Kan Gong”